GlassScriptPhysician profile
Vorice Batts
NPI 1669849311
$11,603.22
in general payments reported to CMS, 2019-2025
21 companies · $491 in 2025
The $491 reported for 2025 was more than what a typical Foot & Ankle Surgery provider received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $6,431 · 2020: $1,393 · 2021: $1,900 · 2022: $867 · 2023: $39.64 · 2024: $481 · 2025: $491.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,012.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,011.50 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $7,554.71 | 2019-2025 | Augment Injectable, Phalinx, Limflow System |
| Smith+Nephew, INC. | $1,588.78 | 2019-2024 | Bioinductive Implant With Arthroscopic Delivery System - Medium |
| Musculoskeletal Transplant Foundation INC. | $465.24 | 2019-2021 | |
| Organogenesis INC. | $439.24 | 2021 | |
| Osiris Therapeutics INC. | $281.80 | 2019 | |
| Bone Support INC. | $268.75 | 2022 | |
| Kci USA, INC. | $247.85 | 2019 | |
| Treace Medical Concepts, INC. | $219.95 | 2022 | |
| Sanara Medtech INC. | $155.45 | 2021 | |
| Kerecis Limited | $135.62 | 2019 | |
| Zimmer Biomet Holdings, INC. | $35.41 | 2019 | |
| Abbott Laboratories | $35.06 | 2024 | Proclaim |
| Tactile Systems Technology INC | $32.63 | 2019-2020 | |
| Grt US Holding, INC. | $31.46 | 2022 | |
| Alafair Biosciences, INC. | $18.53 | 2021 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Allergan, INC. | $18.46 | 2020 | |
| Aroa Biosurgery Incorporated | $16.24 | 2020 | |
| Pacira Pharmaceuticals Incorporated | $15.60 | 2020 | |
| Medinc of Texas | $14.94 | 2025 | |
| Abbvie INC. | $13.78 | 2021 | |
| Triad Life Sciences INC. | $13.72 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Vorice Batts listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.